Last reviewed · How we verify
NCT05811702
The Impact of High-Fat Ketogenic Diet and Low-Fat Diet in Women Body Weight
NA trial testing A randomized acute controlled trial of twenty-eight healthy overweight or obese women in Overweight and Obesity in 28 participants. Status unknown.
1 October 2023
Quick facts
| Lead sponsor | King Faisal University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 28 |
| Start date | 1 July 2023 |
| Primary completion | 1 October 2023 |
| Estimated completion | 1 November 2023 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- A randomized acute controlled trial of twenty-eight healthy overweight or obese women
Conditions studied
- Overweight and Obesity — all drugs for Overweight and Obesity →
- Healthy — all drugs for Healthy →
Sponsor
King Faisal University
Who can join
Adults 18 to 40, female only, with Overweight and Obesity or Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is investigated the effect of high fat Ketogenic Diet (HFKD) in weight reduction compared to the low-fat diet (LFD) among Saudi overweight and obese women. A randomized acute controlled trial of twenty-eight healthy overweight or obese women in Saudi Arabia, aged between 18 and 40 with a body mass index between 25 and 34.5 kg m2 and fat parentage above 30% . The participants have followed ether HFKD or LFD for 12 weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05811702
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overweight and Obesity
Currently open trials in the same condition.
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
- NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
Other King Faisal University trials
Trials by the same sponsor.
- NCT07447505 — Effect of a High-Protein, High-Fiber Pre-Fast Meal on Satiety and Glycemic Profiles During Fasting · NA · recruiting
- NCT07514468 — Effectiveness of Integrative Therapy on Psychological Hardiness Among Hard-of-Hearing Female Students · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05811702 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Faisal University
- Last refreshed: 12 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05811702.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing